Kia expects its first vehicle built on Hyundai's new E-GMP modular electric platform to become their best-selling full-electric car in Europe.
The new Kia EV model would be a crossover with an SUV body style that is growingly popular. It would compete with the likes of the BMW i3 hatchbacks and Volkswagen ID 3.
Kia Europe COO Emilio Herrera expects to sell 10,000 to 15,000 of the EV model in Europe this year, even if it is not expected to go on sale until September.
Herrera didn’t give sales forecasts for 2022, but it could outsell Kia’s two EVs in Europe, the Soul and Niro.
The Soul EV accounted for 8,021 unit sales in Europe last year, while the e-Niro accounted for 31,000.
The e-Niro accounted for 31,000 unit sales in Europe last year, while there were 8,021 Soul EV units sold.
The new E-GMP platform allows 500 km ranges and quicker acceleration.
Kia plans to come up with seven vehicles on the platform globally by 2027.
The company also aims to have 11 full EVs by 2025, which would account for 30 percent of its Euro sales. The lineup would include new models and electric versions of existing vehicles like the Soul EV.


T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
Google Secures Pentagon AI Deal for Classified Projects
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S. 



